Cite
HARVARD Citation
Chang, L. et al. (2021). Safety and immunogenicity of high doses of quadrivalent influenza vaccine in children 6 months through <18 years of age: A randomized controlled phase II dose-finding trial. Vaccine. 39 (11), pp. 1572-1582. [Online].